➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Baxter
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: October 28, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206393


Email this page to a colleague

« Back to Dashboard

NDA 206393 describes NICOTINE POLACRILEX, which is a drug marketed by Ivax Sub Teva Pharms, L Perrigo Co, P And L, Perrigo R And D, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, and Pld Acquisitions, and is included in forty-seven NDAs. It is available from forty-five suppliers. Additional details are available on the NICOTINE POLACRILEX profile page.

The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are thirty drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
Summary for 206393
Tradename:NICOTINE POLACRILEX
Applicant:Perrigo R And D
Ingredient:nicotine polacrilex
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 206393
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 206393 ANDA L. Perrigo Company 0113-0053 0113-0053-06 160 BLISTER PACK in 1 CARTON (0113-0053-06) > 1 GUM, CHEWING in 1 BLISTER PACK
NICOTINE POLACRILEX nicotine polacrilex GUM, CHEWING;BUCCAL 206393 ANDA L. Perrigo Company 0113-0713 0113-0713-06 160 BLISTER PACK in 1 CARTON (0113-0713-06) > 1 GUM, CHEWING in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 4MG BASE
Approval Date:Dec 15, 2016TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Mallinckrodt
Express Scripts
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.